IMCR compared with CMPS: revenue, margins and what each company keeps, and the suppliers and customers both name

IMCRImmunocore Holdings plc

Mkt capRevenueRevenue

CMPSCOMPASS Pathways plc

Mkt capRevenueRevenue

Compare

IMCRImmunocore Holdings plc

CMPSCOMPASS Pathways plc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

IMCR: latest quarter is a loss; flow not drawable. CMPS: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only IMCR 1

—Adaptimmune Therapeuticsunlistedsupplier

Shared 0

No disclosed counterparties: CMPS.

Only CMPS 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

IMCR, solidCMPS, dashed

IMCRImmunocore Holdings plc

30.46▼−2.60%· post 30.46

Mkt cap$1.6BRevenue$116MQ2 FY26Revenue$400MFY25

CMPSCOMPASS Pathways plc

11.57▼−5.09%· post 11.62

ClosedOct 30 '26

Mkt cap$1.6BRevenue—Revenue—

Compare

ClosedOct 30 '26

IMCRImmunocore Holdings plc

CMPSCOMPASS Pathways plc

30.46▼−2.60%post 30.46

Price

11.57▼−5.09%post 11.62

$1.6B

Mkt cap

$1.6B

Q2 FY26$116M

Revenue

—

FY25$400M

Revenue

—

IMCR30.46▼−2.60%vsCMPS11.57▼−5.09%ClosedOct 30 '26